High CD204 expression in TAMs correlates with short overall survival (OS), disease-free survival (DFS) and RFS in colorectal cancer, cervical cancer, breast cancers and oral squamous cell carcinoma (OSCC) (24, 74–76). Here, MSR1 is linked to breast carcinoma.